Vascular News and Research

RSS

Scientists present new research on adipocyte regulation

The ninth Colloque Médecine et Recherche of la Fondation Ipsen devoted to Endocrinology, held in Paris on December 4, 2009, has reviewed the recent progress in understanding the regulation of fat storage in the body and the consequences of the breakdown of this regulation.

14 Dec 2009

Changes to NCQA's disease management Accreditation and Certification standards released

The National Committee for Quality Assurance (NCQA) today released changes to its disease management Accreditation and Certification requirements, adding voluntary performance reporting for five chronic conditions.

14 Dec 2009

Patients with elevated CRP and normal LDL levels may benefit from statin therapy

New research shows a long-term benefit in screening people for CRP, a marker for inflammation, even if they have normal levels of bad cholesterol, because of increased long-term risk for heart attack, stroke and death.

14 Dec 2009

Special issue focuses on cardiovascular disease prevention and outcomes

Emerging research on cardiovascular risk factors and treatment effects are helping clinicians gain a better understanding of which patients are most likely to benefit from close monitoring, lifestyle changes and/or additional therapeutic interventions.

14 Dec 2009

Obese patients loosing moderate amount of weight improve their cardiovascular health, says study

Obese patients who lost a moderate amount of weight by eating less and exercising more improved their cardiovascular health, says a study at Washington University School of Medicine in St. Louis.

14 Dec 2009

New Hill-Rom's Advanta 2 Bed for hospitals and home care facilities

Hill-Rom today announced the introduction of Hill-Rom's Advanta(TM) 2 Bed for use in medical-surgical areas of hospitals and care facilities. The new bed brings together ease of use with key safety features and the flexibility to use a variety of care surfaces as needed.

14 Dec 2009

ThromboGenics initiates Phase II trial of microplasmin for wet AMD

ThromboGenics NV, a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, announces today that it has started a Phase II trial of microplasmin for the treatment of exudative (wet) Age-related Macular Degeneration (AMD).

11 Dec 2009

LLS becomes corporate partner and joins VDF as sponsor

The Vascular Disease Foundation (VDF) announced today that Life Line Screening, Inc. (LLS) has become a corporate partner and joined the foundation as a sponsor.

11 Dec 2009

Vitamin K2 in Hawaiian Spirulina Pacifica

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced its Hawaiian Spirulina Pacifica® has achieved another nutritional first. Already the most nutritious Spirulina in the world, it is also a good source of Vitamin K2.

10 Dec 2009

USC Fetal Therapy Program achieves improved survival rate in TTTS fetal surgery

A Southern California fetal surgery institute, one of only a handful in the United States, has posted enormously successful rates in treating a dangerous disorder that affects 10 percent of unborn identical twins.

10 Dec 2009

Preliminary data from Phase 2 clinical trial of ZFP Therapeutic program presented

Sangamo BioSciences, Inc. announced today the presentation of preliminary data from the Phase 2 clinical trial of its ZFP Therapeutic(TM) program to develop SB-509 as a treatment for amyotrophic lateral sclerosis (ALS) at a Work in Progress session at the 20th International Symposium on ALS/MND held in Berlin, Germany.

9 Dec 2009

New guidelines on the management of antithrombotic agents for endoscopic procedures published

According to a new guideline from the American Society for Gastrointestinal Endoscopy (ASGE) regarding the management of antithrombotic agents for endoscopy, aspirin and/or NSAIDs may be continued for all elective endoscopic procedures.

9 Dec 2009

On-X Life Technologies, Cleveland Clinic enter into an exclusive worldwide license agreement

Austin-based On-X® Life Technologies, Inc., manufacturers of the On-X® Prosthetic Heart Valve, announced today that it has entered into an exclusive worldwide license with the Cleveland Clinic for a system of products intended to improve and simplify the replacement of damaged or severed mitral valve chordae.

9 Dec 2009

University of Texas launches phase II clinical trial to test stem-cell-based therapy on injured heart muscle

The second phase of a clinical trial testing a new stem-cell-based therapy on injured heart muscle has been launched by researchers at The University of Texas Medical School at Houston. It is the only study site in the Texas Medical Center.

9 Dec 2009

Dr. Brian Newman to conduct two training sessions for medical professionals on Veinwave system

Brian Newman, MD, FRCS, will conduct two training sessions for medical professionals on the Veinwave(TM) system, a revolutionary system used by doctors around the world to non-invasively eliminate spider veins and telangiectasia.

9 Dec 2009

Baylor Jack and Jane Hamilton Heart and Vascular Hospital receives AACVPR Innovation Award

For their unique Return to Work Lab which focuses on individualized rehabilitation for younger, more active cardiac patients, the Cardiac Rehabilitation program at the Baylor Jack and Jane Hamilton Heart and Vascular Hospital was recently awarded the Innovation Award from the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR).

8 Dec 2009

Combination of gene and cell therapy improves critical limb ischemia associated with aging or diabetes

Blood vessel blockage, a common condition in old age or diabetes, leads to low blood flow and results in low oxygen, which can kill cells and tissues. Such blockages can require amputation resulting in loss of limbs. Now, using mice as their model, researchers at Johns Hopkins have developed therapies that increase blood flow, improve movement and decrease tissue death and the need for amputation.

8 Dec 2009

ASH meeting highlights H1N1 pandemic threat, new trends and treatment options for children with genetic blood disorder

Sickle cell disease, a condition characterized by deformed and dysfunctional red blood cells, is one of the most common genetic blood disorders affecting millions of people around the world, including more than 70,000 Americans (National Heart, Lung, and Blood Institute.

8 Dec 2009

Study: Besides nerves, skin has a unique sensory system

The human sensory experience is far more complex and nuanced than previously thought, according to a groundbreaking new study published in the December 15, 2009 issue of the journal Pain (http://www.painjournalonline.com/article/S0304-3959%2809%2900526-0/abstract).

8 Dec 2009

Non-clinical data of CK-2017357 presented by Cytokinetics

Cytokinetics, Incorporated announced today that both a poster and an oral presentation summarizing non-clinical data regarding CK-2017357, a novel fast skeletal troponin activator, were presented at the 5th Cachexia Conference, organized by the Society on Cachexia and Wasting Disorders, being held December 5-8, 2009 in Barcelona, Spain.

8 Dec 2009

Vascular News and Research

Scientists present new research on adipocyte regulation

Changes to NCQA's disease management Accreditation and Certification standards released

Patients with elevated CRP and normal LDL levels may benefit from statin therapy

Special issue focuses on cardiovascular disease prevention and outcomes

Obese patients loosing moderate amount of weight improve their cardiovascular health, says study

New Hill-Rom's Advanta 2 Bed for hospitals and home care facilities

ThromboGenics initiates Phase II trial of microplasmin for wet AMD

LLS becomes corporate partner and joins VDF as sponsor

Vitamin K2 in Hawaiian Spirulina Pacifica

USC Fetal Therapy Program achieves improved survival rate in TTTS fetal surgery

Preliminary data from Phase 2 clinical trial of ZFP Therapeutic program presented

New guidelines on the management of antithrombotic agents for endoscopic procedures published

On-X Life Technologies, Cleveland Clinic enter into an exclusive worldwide license agreement

University of Texas launches phase II clinical trial to test stem-cell-based therapy on injured heart muscle

Dr. Brian Newman to conduct two training sessions for medical professionals on Veinwave system

Baylor Jack and Jane Hamilton Heart and Vascular Hospital receives AACVPR Innovation Award

Combination of gene and cell therapy improves critical limb ischemia associated with aging or diabetes

ASH meeting highlights H1N1 pandemic threat, new trends and treatment options for children with genetic blood disorder

Study: Besides nerves, skin has a unique sensory system

Non-clinical data of CK-2017357 presented by Cytokinetics

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News